Article | September 13, 2023

OPDP is Back Sending Untitled Letters after a Yearlong Hiatus

Read More

Article | August 22, 2023

Panel Session Recap: Navigating the M&A Waters of FDA-Regulated Companies

Read More

Article | August 07, 2023

FDA Regulatory, Compliance, and Privacy Due Diligence — Finding Your Goldilocks Zone

Read More

Article | August 07, 2023

Data Privacy Framework Across the Pond

Read More

Article | July 25, 2023

FDA's Proposed Compliance "Revamp": What Does It Mean for the Agency, Industry, and Consumers?

Read More

Article | July 20, 2023

State Registration Enforcement

Read More

Article | July 17, 2023

FDA Publishes First Draft Guidance for Clinical Trials with Psychedelic Drugs

Read More

Article | June 27, 2023

Getting What You Paid For: Acquisition Claims Considerations

Read More

Article | June 21, 2023

Beyond Paperwork: Assessing the Effectiveness of a Compliance Program

Read More

Article | June 14, 2023

New WA Privacy Law ‘Turns The Beat Around’ on Drug and Device Makers

Read More

Article | June 05, 2023

Whose Data Breach Is It Anyway?

Read More

Article | May 31, 2023

Healthcare Enforcement in a Post-Pandemic World

Read More